Crinetics Pharmaceuticals (CRNX) Return on Sales (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Return on Sales came in at 0.12% in Q1 2026, up 256.0% year-on-year from 0.03% in Q1 2025, and up 40.23% quarter-over-quarter from 0.2% in Q4 2025.
Crinetics Pharmaceuticals has reported Return on Sales for 10 years, with the latest figure at 0.12% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 256.0% year-over-year to 0.12%; the trailing twelve-month figure through Mar 2026 stood at 0.27% (up 404.0% YoY), and the FY2025 full-year result was 0.6%, up 226.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.12%, up from 0.2% in the prior quarter.
- The five-year high for Return on Sales was 0.11% in Q1 2022, with the low at 9.1% in Q3 2025.
- Average Return on Sales over 5 years is 1.59%, with a median of 0.96% recorded in 2022.
- Year-over-year, Return on Sales slumped 1479 bps in 2022 and jumped 267 bps in 2025.
- Tracing CRNX's Return on Sales over 5 years: stood at 0.64% in 2022, then increased by 19 bps to 0.52% in 2023, then slumped by 450 bps to 2.87% in 2024, then soared by 93 bps to 0.2% in 2025, then surged by 40 bps to 0.12% in 2026.
- The last three Return on Sales figures came in at 0.12% (Q1 2026), 0.2% (Q4 2025), and 9.1% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -0.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.12% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | -9.10% |
| Jun 30, 2025 | -1.12% |
| Mar 31, 2025 | -2.68% |
| Dec 31, 2024 | -2.87% |
| Sep 30, 2024 | -2.63% |
| Jun 30, 2024 | -1.86% |
| Mar 31, 2024 | -1.03% |
| Dec 31, 2023 | -0.52% |
| Sep 30, 2023 | -1.63% |
| Jun 30, 2023 | -0.52% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | -0.64% |
| Sep 30, 2022 | -0.92% |
| Jun 30, 2022 | -0.96% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | -0.29% |
| Sep 30, 2021 | 13.87% |
| Mar 31, 2021 | 11.21% |
| Dec 31, 2020 | 3.06% |
| Sep 30, 2020 | -1.70% |
| Jun 30, 2020 | -0.70% |
| Mar 31, 2020 | -2.43% |
| Dec 31, 2019 | -0.45% |
| Sep 30, 2019 | -0.29% |
| Jun 30, 2019 | -0.22% |
| Mar 31, 2019 | -0.25% |
| Dec 31, 2018 | -0.11% |
| Sep 30, 2018 | -0.14% |
| Jun 30, 2018 | -0.08% |
| Mar 31, 2018 | -0.12% |
| Dec 31, 2017 | -0.05% |
| Sep 30, 2017 | -0.04% |
| Jun 30, 2017 | -0.02% |